Deacetylation of GD3A as a potential therapeutic strategy for paediatric medulloblastoma
Medulloblastoma survivors frequently suffer from low quality of life as a result of aggressive treatment. New treatments are urgently needed to reduce down-stream sequelae. GD3, an oncofoetal ganglioside, has roles in embryonic brain development and is commonly modified to 9-O-acetyl GD3 (GD3<sup...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Portsmouth
2016
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.714197 |